Drupal.behaviors.print = function(context) {window.print();window.close();}>
MolecularMD Withdraws PMA for Leukemia CDx
September 18, 2012
MolecularMD Withdraws PMA for Leukemia CDx
By
a GenomeWeb staff reporter
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
MolecularMD Seeks FDA Clearance for Leukemia Drug Companion Dx
July 30, 2012 / GenomeWeb Daily News
Qiagen Submits EGFR Companion Dx to FDA
January 15, 2013 / GenomeWeb Daily News
Exact Sciences Submits First Module of PMA for Cologuard MDx Colorectal Cancer Screen to FDA
December 11, 2012 / GenomeWeb Daily News
Dako, Genentech Partner on Regulatory Submission of CDx for Second Breast Cancer Drug
May 1, 2012 / GenomeWeb Daily News
Qiagen Submits Second PMA for Therascreen KRAS Companion Dx
August 5, 2011 / GenomeWeb Daily News